[The role of betaserk in combined treatment of neurosensory hypoacusis and vestibulopathy in childhood].

Betaserk treatment was given to 78 children aged 6 to 14 years suffering from acute or progressive neurosensory hypoacusis (n=62) and vestibulopathy (n=16). The best results were achieved in vestibulopathy in older children. Stable improvement of hearing in the range 10--20 dB was achieved in 16 (30.7%) children, stable hearing stabilization was seen in 32 (61.4%) cases. Betaserk was well tolerated, had no side effects. Thus, betaserk is effective in the treatment of children with vestibulopathy, acute and progressive neurosensory hypoacusis.